2qcn

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:2qcn.jpg|left|200px]]
[[Image:2qcn.jpg|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 2qcn |SIZE=350|CAPTION= <scene name='initialview01'>2qcn</scene>, resolution 1.85&Aring;
+
The line below this paragraph, containing "STRUCTURE_2qcn", creates the "Structure Box" on the page.
-
|SITE= <scene name='pdbsite=AC1:So4+Binding+Site+For+Residue+A+502'>AC1</scene>, <scene name='pdbsite=AC2:U5p+Binding+Site+For+Residue+A+501'>AC2</scene>, <scene name='pdbsite=AC3:U5p+Binding+Site+For+Residue+B+501'>AC3</scene>, <scene name='pdbsite=AC4:Gol+Binding+Site+For+Residue+A+503'>AC4</scene> and <scene name='pdbsite=AC5:Gol+Binding+Site+For+Residue+B+502'>AC5</scene>
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=U5P:URIDINE-5&#39;-MONOPHOSPHATE'>U5P</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Orotidine-5'-phosphate_decarboxylase Orotidine-5'-phosphate decarboxylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.1.1.23 4.1.1.23] </span>
+
or leave the SCENE parameter empty for the default display.
-
|GENE= UMPS ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
+
-->
-
|DOMAIN=
+
{{STRUCTURE_2qcn| PDB=2qcn | SCENE= }}
-
|RELATEDENTRY=[[2qcc|2QCC]], [[2qcd|2QCD]], [[2qce|2QCE]], [[2qcf|2QCF]], [[2qcg|2QCG]], [[2qch|2QCH]], [[2qcl|2QCL]], [[2qcm|2QCM]], [[2v30|2V30]], [[2jgy|2JGY]]
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2qcn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2qcn OCA], [http://www.ebi.ac.uk/pdbsum/2qcn PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2qcn RCSB]</span>
+
-
}}
+
'''Covalent complex of the orotidine-5'-monophosphate decarboxylase domain of human UMP synthase with 6-iodo-UMP'''
'''Covalent complex of the orotidine-5'-monophosphate decarboxylase domain of human UMP synthase with 6-iodo-UMP'''
Line 31: Line 28:
[[Category: Rudolph, M.]]
[[Category: Rudolph, M.]]
[[Category: Wittmann, J.]]
[[Category: Wittmann, J.]]
-
[[Category: alternative splicing]]
+
[[Category: Alternative splicing]]
-
[[Category: catalytic proficiency]]
+
[[Category: Catalytic proficiency]]
-
[[Category: decarboxylase]]
+
[[Category: Decarboxylase]]
-
[[Category: disease mutation]]
+
[[Category: Disease mutation]]
-
[[Category: glycosyltransferase]]
+
[[Category: Glycosyltransferase]]
-
[[Category: lyase]]
+
[[Category: Lyase]]
-
[[Category: multifunctional enzyme]]
+
[[Category: Multifunctional enzyme]]
-
[[Category: polymorphism]]
+
[[Category: Polymorphism]]
-
[[Category: pyrimidine biosynthesis]]
+
[[Category: Pyrimidine biosynthesis]]
-
[[Category: transferase]]
+
[[Category: Transferase]]
-
[[Category: ump synthase]]
+
[[Category: Ump synthase]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 14:44:17 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 04:47:44 2008''
+

Revision as of 11:44, 4 May 2008

Template:STRUCTURE 2qcn

Covalent complex of the orotidine-5'-monophosphate decarboxylase domain of human UMP synthase with 6-iodo-UMP


Contents

Overview

UMP synthase (UMPS) catalyzes the last two steps of de novo pyrimidine nucleotide synthesis and is a potential cancer drug target. The C-terminal domain of UMPS is orotidine-5'-monophosphate decarboxylase (OMPD), a cofactor-less yet extremely efficient enzyme. Studies of OMPDs from micro-organisms led to the proposal of several noncovalent decarboxylation mechanisms via high-energy intermediates. We describe nine crystal structures of human OMPD in complex with substrate, product, and nucleotide inhibitors. Unexpectedly, simple compounds can replace the natural nucleotides and induce a closed conformation of OMPD, defining a tripartite catalytic site. The structures outline the requirements drugs must meet to maximize therapeutic effects and minimize cross-species activity. Chemical mimicry by iodide identified a CO(2) product binding site. Plasticity of catalytic residues and a covalent OMPD-UMP complex prompt a reevaluation of the prevailing decarboxylation mechanism in favor of covalent intermediates. This mechanism can also explain the observed catalytic promiscuity of OMPD.

Disease

Known disease associated with this structure: Oroticaciduria OMIM:[258900]

About this Structure

2QCN is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structures of the human orotidine-5'-monophosphate decarboxylase support a covalent mechanism and provide a framework for drug design., Wittmann JG, Heinrich D, Gasow K, Frey A, Diederichsen U, Rudolph MG, Structure. 2008 Jan;16(1):82-92. PMID:18184586 Page seeded by OCA on Sun May 4 14:44:17 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools